Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1967 Dec;43(506):756–762. doi: 10.1136/pgmj.43.506.756

Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias.

V Parsons, D Jewitt
PMCID: PMC2466415  PMID: 6079199

Full text

PDF
757

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BREWSTER W. R., Jr, ISAACS J. P., OSGOOD P. F., KING T. L. The hemodynamic and metabolic interrelationships in the activity of epinephrine, norepinephrine and the thyroid hormones. Circulation. 1956 Jan;13(1):1–20. doi: 10.1161/01.cir.13.1.1. [DOI] [PubMed] [Google Scholar]
  2. BURSTEIN J., LAMBERG B. A., ERAMAA E. Myocardial infarction in thyrotoxicosis. Acta Med Scand. 1960 Apr 20;166:379–393. doi: 10.1111/j.0954-6820.1960.tb17392.x. [DOI] [PubMed] [Google Scholar]
  3. Blumenthal M., Davis R., Doe R. P. Carcinoid syndrome following reserpine therapy in thyrotoxicosis. Arch Intern Med. 1965 Dec;116(6):819–823. [PubMed] [Google Scholar]
  4. Bowness J. M. Epinephrine: cascade reactions and glycogenolytic effect. Science. 1966 Jun 3;152(3727):1370–1371. doi: 10.1126/science.152.3727.1370. [DOI] [PubMed] [Google Scholar]
  5. Bressler R., Wittels B. The effect of thyroxine on lipid and carbohdrate metabolism in the heart. J Clin Invest. 1966 Aug;45(8):1326–1333. doi: 10.1172/JCI105439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CANARY J. J., SCHAAF M., DUFFY B. J., Jr, KYLE L. H. Effects of oral and intramuscular administration of reserpine in thyrotoxicosis. N Engl J Med. 1957 Sep 5;257(10):435–442. doi: 10.1056/NEJM195709052571001. [DOI] [PubMed] [Google Scholar]
  7. COOKSON H. The thyroid and the heart. Br Med J. 1959 Jan 31;1(5117):254–259. doi: 10.1136/bmj.1.5117.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Doherty J. E., Perkins W. H. Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease. Ann Intern Med. 1966 Mar;64(3):489–507. doi: 10.7326/0003-4819-64-3-489. [DOI] [PubMed] [Google Scholar]
  9. GORDON J. A., LENKEI S. C. THYROTOXICOSIS ASSOCIATED WITH MYOCARDIAL INFARCTION. Can Med Assoc J. 1964 May 9;90:1128–1129. [PMC free article] [PubMed] [Google Scholar]
  10. GREEN K., MATTY A. J. Action of thyroxine on active transport in isolated membranes of Bufo bufo. Gen Comp Endocrinol. 1963 Jun;3:244–252. doi: 10.1016/0016-6480(63)90019-4. [DOI] [PubMed] [Google Scholar]
  11. GRYTTING G., SALVESEN H. A. Thyrotoxicosis and myocardial infarction. Acta Med Scand. 1957 Apr 18;157(3):169–171. doi: 10.1111/j.0954-6820.1957.tb14422.x. [DOI] [PubMed] [Google Scholar]
  12. Gompertz D., Greenbaum A. L. The effects of thyroxine on the pattern of fatty acid synthesis in rat liver. Biochim Biophys Acta. 1966 Jun 1;116(3):441–459. doi: 10.1016/0005-2760(66)90114-7. [DOI] [PubMed] [Google Scholar]
  13. HARRISON T. S. ADRENAL MEDULLARY AND THYROID RELATIONSHIPS. Physiol Rev. 1964 Apr;44:161–185. doi: 10.1152/physrev.1964.44.2.161. [DOI] [PubMed] [Google Scholar]
  14. Howitt G., Rowlands D. J. Beta-sympathetic blockade in hyperthyroidism. Lancet. 1966 Mar 19;1(7438):628–631. doi: 10.1016/s0140-6736(66)90825-7. [DOI] [PubMed] [Google Scholar]
  15. Ingbar S. H. Management of emergencies. IX. Thyrotoxic storm. N Engl J Med. 1966 Jun 2;274(22):1252–1254. doi: 10.1056/NEJM196606022742209. [DOI] [PubMed] [Google Scholar]
  16. LEAK D. Adrenergic blockade and thyrotoxicosis. Acta Endocrinol (Copenh) 1963 May;43:131–136. doi: 10.1530/acta.0.0430131. [DOI] [PubMed] [Google Scholar]
  17. LUCCHESI B. R. THE EFFECTS OF PRONETHALOL AND ITS DEXTRO ISOMER UPON EXPERIMENTAL CARDIAC ARRHYTHMIAS. J Pharmacol Exp Ther. 1965 Apr;148:94–99. [PubMed] [Google Scholar]
  18. MCMICHAEL J. The heart and digitalis. Br Med J. 1963 Jul 13;2(5349):73–79. doi: 10.1136/bmj.2.5349.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. MORALES AGUILERA A., VAUGHANWILLIAMS E. M. THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS. Br J Pharmacol Chemother. 1965 Apr;24:332–338. doi: 10.1111/j.1476-5381.1965.tb01719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Murmann W., Almirante L., Saccani-Guelfi M. Central nervous system effects of four beta-adrenergic receptor blocking agents. J Pharm Pharmacol. 1966 May;18(5):317–318. doi: 10.1111/j.2042-7158.1966.tb07878.x. [DOI] [PubMed] [Google Scholar]
  21. Oddie T. H., Meade J. H., Jr, Fisher D. A. An analysis of published data on thyroxine turnover in human subjects. J Clin Endocrinol Metab. 1966 Apr;26(4):425–436. doi: 10.1210/jcem-26-4-425. [DOI] [PubMed] [Google Scholar]
  22. ROWLANDS D. J., HOWITT G., MARKMAN P. PROPRANOLOL (INDERAL) IN DISTURBANCES OF CARDIAC RHYTHM. Br Med J. 1965 Apr 3;1(5439):891–894. doi: 10.1136/bmj.1.5439.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Robison G. A., Butcher R. W., Oye I., Morgan H. E., Sutherland E. W. The effect of epinephrine on adenosine 3', 5'-phosphate levels in the isolated perfused rat heart. Mol Pharmacol. 1965 Sep;1(2):168–177. [PubMed] [Google Scholar]
  24. SANDLER G., WILSON G. M. The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I. Q J Med. 1959 Jul;28:347–369. [PubMed] [Google Scholar]
  25. Schatz D. L. Serum free thyroxine and thyroxine-binding protein studies in patients with supraventricular tachycardias. J Clin Endocrinol Metab. 1967 Feb;27(2):165–172. doi: 10.1210/jcem-27-2-165. [DOI] [PubMed] [Google Scholar]
  26. Staffurth J. S., Gibberd M. C., Hilton P. J. Atrial fibrillation in thyrotoxicosis treated with radioiodine. Postgrad Med J. 1965 Nov;41(481):663–671. doi: 10.1136/pgmj.41.481.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. WALDSTEIN S. S., WEST G. H., Jr, LEE W. Y., BRONSKY D. GUANETHIDINE IN HYPERTHYROIDISM. JAMA. 1964 Aug 24;189:609–612. doi: 10.1001/jama.1964.03070080015003. [DOI] [PubMed] [Google Scholar]
  28. WILSON W. R., THEILEN E. O., FLETCHER F. W. PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM. J Clin Invest. 1964 Aug;43:1697–1703. doi: 10.1172/JCI105045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. WISWELL J. G., HURWITZ G. E., CORONHO V., BING O. H., CHILD D. L. URINARY CATECHOL AMINES AND THEIR METABOLITES IN HYPERTHYROIDISM AND HYPOTHYROIDISM. J Clin Endocrinol Metab. 1963 Nov;23:1102–1106. doi: 10.1210/jcem-23-11-1102. [DOI] [PubMed] [Google Scholar]
  30. Williamson J. R. Metabolic effects of epinephrine in the perfused rat heart. II. Control steps of glucose and glycogen metabolism. Mol Pharmacol. 1966 May;2(3):206–220. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES